To CANCER IMMUNITY Home Page

Figure 1

Solid phase ELISA of ascites fluid from 11 newly generated anti-CT10/MAGE-C2 clones (LX-CT10.1 to LX-CT10.12). (A) Titration assay using ascites from clones LX-CT10.1 to LX-CT10.12 and full-length recombinant CT10/MAGE-C2 protein. (B) Specificity analysis showing reactivity with CT10/MAGE-C2 and no reactivity with CT antigens NY-ESO-1, SSX2, MAGE-A3, CT7, and CT16.

 

Copyright © 2006 by Boquan Jin